Low prevalence of the APC 11307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease

Jing Yin, Noam Harpaz, Rhonda F. Souza, Tongtong Zou, Dehe Kong, Suna Wang, Anatoly L. Leytin, Neil S. Medalie, Kara N. Smolinski, John M. Abraham, Steven A. Fleisher, Stephen J. Meltzer

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


A germline sequence alteration at codon 1307 of the APC gene (I1307K) has been reported in 6-7% of the Ashkenazi Jewish population in the United States. This alteration is believed to predispose the APC gene to a secondary mutation at the same locus, resulting in an increased risk of colorectal carcinoma. There is an increased risk of colorectal carcinoma in patients with inflammatoray bowel disease (IBD), a relatively large proportion of whom are Ashkenazi Jews. We therefore sought to determine whether the I1307K sequence variant occurred in the germline DNA of IBD patients. To our surprise, we found this sequence in only two of 267 patients with IBD (0.7%), occurring in only 1.5% of Jewish IBD patients. The I1307K sequence variant was not found in 67 patients, with esophageal cancer, 53 patients with gastric carcinoma (13 MSI-H and 44 MSI-negative), or ten patients with sporadic MSI-H colon cancer. These findings suggest that the I1307K sequence is relatively rare in the germline of Jewish as well as non-Jewish IBD patients. It does not appear to contribute to the increased colorectal cancer risk present in these patients.

Original languageEnglish (US)
Pages (from-to)3902-3904
Number of pages3
Issue number26
StatePublished - Jul 1 1999


  • APC gene
  • Cancer genetics
  • Colorectal carcinoma
  • I1307k sequence
  • Inflammatory bowel disease
  • Jewish

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Low prevalence of the APC 11307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this